Clinical trial comparing effect of Paracetamol and Ketorolac on pain management after cardiac surgery in children

Effect of Paracetamol and Ketorolac on pain management after cardiac surgery in children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015012320759N1

Enrollment

Registered

2015-09-15

Start date

2014-08-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Precordial pain. Precordial pain

Interventions

Intervention 1: Intervention group 1 : Paracetamol as commercial name Apotel made by Couble drug company with dose of 15 mg per kg every 6 hours was used for 48 hours. Intervention 2: Intervention gr

Treatment - Drugs

Intervention group 1 : Paracetamol as commercial name Apotel made by Couble drug company with dose of 15 mg per kg every 6 hours was used for 48 hours.

Intervention group 2 : Ketorolac intravenous with dose of 0.5 mg per kg every 6 hours made by Exir company was used for 48 hours.

Eligibility

Sex/Gender

All

Age

91 Years to 81 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patients undergoing cardiac surgery; children between the age of 12-2 years. Exclusion criteria: patient dissatisfaction; addiction; drug allergy. Ketorolac groups: patients with renal insufficiency. Parecetamol group having allergies; liver failure; renal failure

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Every 1 hour to 24 hours after the second day every 4 hours for 48 hours. Method of measurement: CPOT (Critical-care Pain Observation Tool).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ghasem Soltani

Mashhad University of Medical Science

Soltanigh@mums.ac.ir+98 51 3852 5209

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026